Amit Munshi insider trades: Inhibikase Therapeutics (IKT) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Amit reports to the SEC
and 1 more company
Open-market buys and sales
21 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 21, 2024 | IKT | ↑ Buy | 365,000 | $1.37 | $500K | By Amit Munshi Revocable Trust | Oct 23, 2024 (2d) |
| Apr 22, 2024 | ZURA | ↑ Buy | 159,744 | $3.13 | $500K | Direct | Apr 24, 2024 (2d) |
| Jun 5, 2023 | ZURA | ↑ Buy | 117,647 | $4.25 | $500K | Direct | Jun 5, 2023 (0d) |
| Aug 16, 2021 | ARNA | ↑ Buy | 1,000 | $48.19 | $48K | Direct | Aug 17, 2021 (1d) |
| Aug 12, 2021 | ARNA | ↑ Buy | 1,000 | $50.41 | $50K | Direct | Aug 13, 2021 (1d) |
| Aug 10, 2021 | ARNA | ↑ Buy | 1,000 | $52.91 | $53K | Direct | Aug 11, 2021 (1d) |
| Jan 19, 2021 | ARNA | ↓ Sell | 100,000 | $80.19 | $8.0M | Direct | Jan 20, 2021 (1d) |
| Jan 12, 2021 | ARNA | ↓ Sell | 14,877 | $75.12 | $1.1M | Direct | Jan 14, 2021 (2d) |
| Dec 8, 2020 | ARNA | ↓ Sell | 6,517 | $70.00 | $456K | Direct | Dec 9, 2020 (1d) |
| Aug 31, 2020 | ARNA | ↓ Sell | 100,000 | $70.05 | $7.0M | Direct | Aug 31, 2020 (0d) |
| Jun 3, 2020 | ARNA | ↓ Sell | 100,000 | $66.77 | $6.7M | Direct | Jun 4, 2020 (1d) |
| May 22, 2020 | ARNA | ↓ Sell | 84,800 | $56.28 | $4.8M | Direct | May 22, 2020 (0d) |
| Feb 13, 2020 | ARNA | ↓ Sell | 15,200 | $55.00 | $836K | Direct | Feb 14, 2020 (1d) |
| Feb 5, 2020 | ARNA | ↓ Sell | 7,129 | $50.00 | $356K | Direct | Feb 7, 2020 (2d) |
| May 12, 2017 | ARNA | ↑ Buy | 25,000 | $1.19 | $30K | Direct | May 15, 2017 (3d) |
| Apr 26, 2017 | ARNA | ↑ Buy | 50,000 | $1.41 | $71K | Direct | Apr 27, 2017 (1d) |
| Dec 16, 2015 | EPRS | ↑ Buy | 8,270 | $2.80 | $23K | Indirect | Dec 17, 2015 (1d) |
| Dec 15, 2015 | EPRS | ↑ Buy | 8,069 | $2.87 | $23K | Indirect | Dec 16, 2015 (1d) |
| Dec 9, 2015 | EPRS | ↑ Buy | 13,190 | $4.07 | $54K | Indirect | Dec 10, 2015 (1d) |
| Sep 21, 2015 | EPRS | ↑ Buy | 10,000 | $6.19 | $62K | Indirect | Sep 22, 2015 (1d) |
| Sep 18, 2015 | EPRS | ↑ Buy | 10,000 | $5.99 | $60K | Indirect | Sep 21, 2015 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other IKT insiders
Open-market trades in the last 12 months
About Amit Munshi's insider trades
Amit Munshi is an insider at Inhibikase Therapeutics (IKT). Since Sep 18, 2015, Amit has reported 13 open-market purchases worth $2.0M and 8 sales worth $29.2M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (31 filings), option exercises (10 filings), shares withheld for taxes (4 filings), other transactions (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IKT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.